[1]
“Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations ”, Rev Diabet Stud, vol. 6, no. 2, Aug. 2023, Accessed: Sep. 13, 2025. [Online]. Available: https://diabeticstudies.org/index.php/RDS/article/view/263